Related Experiment Videos
Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases
The Biochemical Journal
|August 1, 1983
Summary
Polyamines like spermine inhibit specific calcium-dependent protein kinases, but not cyclic nucleotide-dependent ones. These findings suggest polyamines may regulate cellular signaling pathways involving calcium-dependent protein phosphorylation in vivo.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Signaling
Background:
- Protein kinases are crucial enzymes regulating cellular processes.
- Calcium-dependent protein kinases (Ca2+-PKs) play vital roles in signal transduction.
- Polyamines are ubiquitous cellular polycations with diverse biological functions.
Purpose of the Study:
- To investigate the effects of various polyamines on different protein kinases.
- To determine the inhibitory potency and kinetic mechanisms of polyamines on Ca2+-PKs.
- To explore the potential in vivo regulatory roles of polyamines in Ca2+-PK systems.
Main Methods:
- Enzyme inhibition assays were performed using purified protein kinases.
- Kinetic analysis (competitive, non-competitive inhibition) was conducted.
- Phosphorylation of endogenous proteins in rat brain particulate fractions was assessed.
Main Results:
- Polyamines, particularly spermine and 1,12-diaminododecane, inhibited phospholipid-sensitive Ca2+-PK and myosin light-chain kinase.
- Inhibitory potency varied among polyamines, with spermine and 1,12-diaminododecane being most potent.
- Polyamines showed negligible effects on cyclic AMP- and cyclic GMP-dependent protein kinases.
- Spermine significantly inhibited Ca2+- and calmodulin-stimulated phosphorylation of endogenous proteins.
Conclusions:
- Polyamines act as inhibitors of specific Ca2+-dependent protein kinases, distinct from cyclic nucleotide-dependent kinases.
- The differential inhibition and high cellular concentrations suggest polyamines, especially spermine, may regulate Ca2+-PK systems in vivo.
- Polyamines represent a class of polycationic inhibitors for Ca2+-PKs, alongside previously identified lipophilic compounds and polypeptides.